Loading resource…

Imperial College London
The document discusses the importance of cardiovascular disease prevention and effective lipid management as a long-term priority. It highlights the recommendations from NICE CG181 regarding statin therapy for patients with a high risk of atherosclerotic cardiovascular disease (ASCVD). Additionally, it reviews the accumulation of clinical trial evidence for various lipid-lowering agents and the differences between NICE guidelines and those from other international societies.
No account needed